Open Innovation between established and emerging bio-pharmaceuticals
In the UK, early stage bio-pharmaceutical companies gain enhanced patenting performance through Open Innovation in contrast to the established companies, which experienced challenges. This is one for the findings by Despoina Filiou and is contrary to the experience in...
Read moreCollaborative innovation in a time of social distancing – 5 things we now know
Like so many meetings, the IfM’s Open Innovation Forum's March workshop, was hastily reconvened into a virtual event due to the coronavirus crisis. Co-organiser Dominic Oughton, discusses some of the learning points.
Read moreRenault is on track for autonomous driving
Scenario identification is creating use case definitions for real world driving safety critical scenarios, explains Rémi Bastien, Vice President for Automotive Prospective, Renault Group.
Read moreLeveraging Open Innovation for societal impact – an R&D Management special issue
How could open innovation (OI) collaborative practices provide a way to tackle the world’s most pressing societal challenges – eradication of disease? Reduction of carbon emissions? Creation of more sustainable products and services? A special issue of R&D Management...
Read more